Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab

Research output: Unpublished contribution to conferenceUnpublished abstract

Fingerprint

Dive into the research topics of 'Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences